BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31258036)

  • 1. A Mobile Buprenorphine Treatment Program for Homeless Patients With Opioid Use Disorder.
    Buzza C; Elser A; Seal J
    Psychiatr Serv; 2019 Jul; 70(7):635-636. PubMed ID: 31258036
    [No Abstract]   [Full Text] [Related]  

  • 2. A Community Partnership to Improve Access to Buprenorphine in a Homeless Population.
    Leo P; Gastala N; Fleurimont J; Messmer S; Maes P; Richardson J; Neeb C; Stackhouse N; Koruba S; Watson DP
    Ann Fam Med; 2021; 19(1):85. PubMed ID: 33431401
    [No Abstract]   [Full Text] [Related]  

  • 3. Expanding low-threshold buprenorphine to justice-involved individuals through mobile treatment: Addressing a critical care gap.
    Krawczyk N; Buresh M; Gordon MS; Blue TR; Fingerhood MI; Agus D
    J Subst Abuse Treat; 2019 Aug; 103():1-8. PubMed ID: 31229187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of women treated with buprenorphine during pregnancy.
    Alto WA; O'Connor AB
    Am J Obstet Gynecol; 2011 Oct; 205(4):302-8. PubMed ID: 21640969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buprenorphine shared medical appointments for the treatment of opioid dependence in a homeless clinic.
    Doorley SL; Ho CJ; Echeverria E; Preston C; Ngo H; Kamal A; Cunningham CO
    Subst Abus; 2017; 38(1):26-30. PubMed ID: 27897918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicines for Patients After an Opioid Overdose.
    Ann Intern Med; 2018 Aug; 169(3):. PubMed ID: 29913484
    [No Abstract]   [Full Text] [Related]  

  • 7. Office-Based Opioid Treatment with Buprenorphine (OBOT-B): Statewide Implementation of the Massachusetts Collaborative Care Model in Community Health Centers.
    LaBelle CT; Han SC; Bergeron A; Samet JH
    J Subst Abuse Treat; 2016 Jan; 60():6-13. PubMed ID: 26233698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-Barrier Buprenorphine Treatment for People Experiencing Homelessness.
    Gibson CL; Lo E
    Psychiatr Serv; 2023 Jan; 74(1):104. PubMed ID: 36254451
    [No Abstract]   [Full Text] [Related]  

  • 9. Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study.
    Larochelle MR; Bernson D; Land T; Stopka TJ; Wang N; Xuan Z; Bagley SM; Liebschutz JM; Walley AY
    Ann Intern Med; 2018 Aug; 169(3):137-145. PubMed ID: 29913516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom.
    Hickman M; Steer C; Tilling K; Lim AG; Marsden J; Millar T; Strang J; Telfer M; Vickerman P; Macleod J
    Addiction; 2018 Aug; 113(8):1461-1476. PubMed ID: 29672985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving care for hospitalized, opioid-dependent patients: a promising start.
    Kushel M
    JAMA Intern Med; 2014 Aug; 174(8):1377-8. PubMed ID: 24978013
    [No Abstract]   [Full Text] [Related]  

  • 12. Medication-Assisted Treatment of Opioid Use Disorder in Adolescents and Young Adults.
    Cottrill CB; Matson SC
    Adolesc Med State Art Rev; 2014 Aug; 25(2):251-65. PubMed ID: 27132312
    [No Abstract]   [Full Text] [Related]  

  • 13. Treating homeless opioid dependent patients with buprenorphine in an office-based setting.
    Alford DP; LaBelle CT; Richardson JM; O'Connell JJ; Hohl CA; Cheng DM; Samet JH
    J Gen Intern Med; 2007 Feb; 22(2):171-6. PubMed ID: 17356982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Best Practices for Acute and Chronic Management of Patients with Opioid Use Disorder.
    Peterkin A; Laks J; Weinstein ZM
    Med Clin North Am; 2022 Jan; 106(1):61-80. PubMed ID: 34823735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between prescribed benzodiazepines, overdose death and buprenorphine discontinuation among people receiving buprenorphine.
    Park TW; Larochelle MR; Saitz R; Wang N; Bernson D; Walley AY
    Addiction; 2020 May; 115(5):924-932. PubMed ID: 31916306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between Participation in Counseling and Retention in a Buprenorphine-Assisted Treatment Program for People Experiencing Homelessness with Opioid Use Disorder.
    Berry ARW; Finlayson TL; Mellis LM; Urada LA
    Int J Environ Res Public Health; 2021 Oct; 18(21):. PubMed ID: 34769591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commentary on Holland et al. (2014): Opioid maintenance treatment--how much supervision is helpful?
    Koller G
    Addiction; 2014 Apr; 109(4):608-9. PubMed ID: 24605959
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of Duration of Methadone or Buprenorphine Use During Pregnancy With Risk of Nonfatal Drug Overdose Among Pregnant Persons With Opioid Use Disorder in the US.
    Jarlenski M; Chen Q; Gao A; Rothenberger SD; Krans EE
    JAMA Netw Open; 2022 Apr; 5(4):e227964. PubMed ID: 35438758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of an Opiate Overdose Educational Intervention and Naloxone Prescribing Program in Homeless Adults Who Use Opiates.
    Pietrusza LM; Puskar KR; Ren D; Mitchell AM
    J Addict Nurs; 2018; 29(3):188-195. PubMed ID: 30180005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute Care, Prescription Opioid Use, and Overdose Following Discontinuation of Long-Term Buprenorphine Treatment for Opioid Use Disorder.
    Williams AR; Samples H; Crystal S; Olfson M
    Am J Psychiatry; 2020 Feb; 177(2):117-124. PubMed ID: 31786933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.